Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Laudermilk

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Behavioural Brain Research|May 18, 2020
Behavioral assessment of rimonabant under acute and chronic conditionsRobert Ettaro, Lucas Laudermilk, Stewart D Clark, et al.
Molecules (Basel, Switzerland)|September 9, 2022
Structure-Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074George Amato, Vineetha Vasukuttan, Danni Harris, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in MiceNayaab Khan, Lucas Laudermilk, Jalen Ware, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2023
Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonistsGeorge Amato, Scott Runyon, Vineetha Vasukuttan, et al.
Journal of Medicinal Chemistry|October 20, 2025
Development of Central Nervous System-Penetrant Apelin Receptor AgonistsSanju Narayanan, Vineetha Vasukuttan, Lucas Laudermilk, et al.
Bioorganic & Medicinal Chemistry|July 27, 2025
Indazole partial agonists targeting peripheral cannabinoid receptorsGeorge Amato, Lucas Laudermilk, Vineetha Vasukuttan, et al.
ACS Chemical Neuroscience|June 24, 2026
Comprehensive Evaluation of Indazole-Based Synthetic Cannabinoid Receptor Agonists with Aliphatic Tail Groups: In Vitro Activities, Metabolic Stability, and In Vivo PharmacokineticsThuy Nguyen, Vineetha Vasukuttan, Lucas Laudermilk, et al.
Journal of Medicinal Chemistry|August 13, 2021
Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship StudiesMd Toufiqur Rahman, Ann M Decker, Lucas Laudermilk, et al.
Journal of Medicinal Chemistry|March 11, 2021
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in MiceSanju Narayanan, Shaobin Wang, Vineetha Vasukuttan, et al.
Journal of Medicinal Chemistry|November 18, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 AgonistsMd Toufiqur Rahman, Ann M Decker, Tiffany L Langston, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Behavioural Brain Research|May 18, 2020
Behavioral assessment of rimonabant under acute and chronic conditionsRobert Ettaro, Lucas Laudermilk, Stewart D Clark, et al.
Molecules (Basel, Switzerland)|September 9, 2022
Structure-Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074George Amato, Vineetha Vasukuttan, Danni Harris, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in MiceNayaab Khan, Lucas Laudermilk, Jalen Ware, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2023
Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonistsGeorge Amato, Scott Runyon, Vineetha Vasukuttan, et al.
Journal of Medicinal Chemistry|October 20, 2025
Development of Central Nervous System-Penetrant Apelin Receptor AgonistsSanju Narayanan, Vineetha Vasukuttan, Lucas Laudermilk, et al.
Bioorganic & Medicinal Chemistry|July 27, 2025
Indazole partial agonists targeting peripheral cannabinoid receptorsGeorge Amato, Lucas Laudermilk, Vineetha Vasukuttan, et al.
ACS Chemical Neuroscience|June 24, 2026
Comprehensive Evaluation of Indazole-Based Synthetic Cannabinoid Receptor Agonists with Aliphatic Tail Groups: In Vitro Activities, Metabolic Stability, and In Vivo PharmacokineticsThuy Nguyen, Vineetha Vasukuttan, Lucas Laudermilk, et al.
Journal of Medicinal Chemistry|August 13, 2021
Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship StudiesMd Toufiqur Rahman, Ann M Decker, Lucas Laudermilk, et al.
Journal of Medicinal Chemistry|March 11, 2021
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in MiceSanju Narayanan, Shaobin Wang, Vineetha Vasukuttan, et al.
Journal of Medicinal Chemistry|November 18, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 AgonistsMd Toufiqur Rahman, Ann M Decker, Tiffany L Langston, et al.
Pageof 1